Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Transgene Biotek Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Transgene Biotek Limited - Product Pipeline Review - 2014', provides an overview of the Transgene Biotek Limited's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Transgene Biotek Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Transgene Biotek Limited including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Transgene Biotek Limited's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Transgene Biotek Limited's pipeline products Reasons to buy - Evaluate Transgene Biotek Limited's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Transgene Biotek Limited in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Transgene Biotek Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Transgene Biotek Limited and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Transgene Biotek Limited - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Transgene Biotek Limited and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Transgene Biotek Limited Snapshot 5 Transgene Biotek Limited Overview 5 Key Information 5 Key Facts 5 Transgene Biotek Limited - Research and Development Overview 6 Key Therapeutic Areas 6 Transgene Biotek Limited - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Transgene Biotek Limited - Pipeline Products Glance 12 Transgene Biotek Limited - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Transgene Biotek Limited - Drug Profiles 13 insulin human 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 TBL-0306C 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 TBL-0306L 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 TBL-0306M 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 TBL-0404 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 TBL-0805E 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 TBL-0905 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 TBL-1003AB 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 TBL-1004HI 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Transgene Biotek Limited - Pipeline Analysis 22 Transgene Biotek Limited - Pipeline Products by Target 22 Transgene Biotek Limited - Pipeline Products by Route of Administration 23 Transgene Biotek Limited - Pipeline Products by Molecule Type 24 Transgene Biotek Limited - Pipeline Products by Mechanism of Action 25 Transgene Biotek Limited - Dormant Projects 26 Transgene Biotek Limited - Locations And Subsidiaries 27 Head Office 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 29 Disclaimer 29
List of Tables Transgene Biotek Limited, Key Information 5 Transgene Biotek Limited, Key Facts 5 Transgene Biotek Limited - Pipeline by Indication, 2014 7 Transgene Biotek Limited - Pipeline by Stage of Development, 2014 8 Transgene Biotek Limited - Monotherapy Products in Pipeline, 2014 9 Transgene Biotek Limited - Partnered Products in Pipeline, 2014 10 Transgene Biotek Limited - Partnered Products/ Combination Treatment Modalities, 2014 11 Transgene Biotek Limited - Preclinical, 2014 12 Transgene Biotek Limited - Pipeline by Target, 2014 22 Transgene Biotek Limited - Pipeline by Route of Administration, 2014 23 Transgene Biotek Limited - Pipeline by Molecule Type, 2014 24 Transgene Biotek Limited - Pipeline Products by Mechanism of Action, 2014 25 Transgene Biotek Limited - Dormant Developmental Projects,2014 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.